Drug Companies Plan to Use Compounding Bill to Eliminate Competition

Administrator 0 Health Impact News
Print Email

S.959, the Senate compounding pharmacy bill, will likely shut off access to important medications like bioavailable estriol and time-released natural thyroid. Special interests in the pharmaceutical industry would try to use the call for federal regulation of compounding pharmacies to outlaw compounded estriol and thyroid and replace them with standard drugs. Compounded, bioidentical estriol became popular in the first place because the standard drug used for the same purpose was proven to be dangerous, a risk for both heart disease and cancer. It would be understandable that the drug companies would want this huge market back.
Read Full Article


You can contact us at: